Vision-Sciences, Inc. Announces Revenue Of $4.5 Million For Third Quarter And $12.1 Million For First Nine Months Of Fiscal 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ORANGEBURG, N.Y., Feb. 3, 2014 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath® technology, today announced financial results for the third quarter and first nine months of fiscal year 2014, ended December 31, 2013.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC